The Lung Attack Alert Study

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

January 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
BEHAVIORAL

Opinion leader educational letter

All patients will receive prednisone X 10 days and antibiotics X 5 days, as well as an opinion leader educational letter sent to the primary care provider outlining the needs of this patient.

Trial Locations (2)

T6G2B7

University of Alberta Hospital Emergency Department, Edmonton

Unknown

Northeaset Community Health Clinic, Edmonton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Alberta

OTHER

NCT01107613 - The Lung Attack Alert Study | Biotech Hunter | Biotech Hunter